Answers are grounded in this paper and cite their sources.
Background and objective Embolization of large spontaneous portosystemic shunts (SPSSs) has emerged as a treatment for hepatic encephalopathy (HE). This retrospective multicenter Australian study investigated outcomes of SPSS embolization for persistent HE. Design Patients with cirrhosis and overt HE (grade II or more) from January 2000 to April 2025 were studied for recurrence of HE 3- and 12-month post-embolization using competing-risks analysis, along with change in maximum HE grade, ascites, variceal bleeding, and hospitalisations 1 year before and after embolization. A case–control study considering cumulative incidence of HE, liver-related death (LRD) or liver transplant (LT) was compared to those with HE and large SPSSs with no embolization from the Baveno-VI-SPSS database. Results Of 95 patients that underwent SPSS embolization with a median baseline MELD of 13 (IQR 11–16), 86 and 72% remained free of HE at 3 and 6 months. One year prior to embolization, 57 (60%) patients had West-Haven grade 3–4 HE, and 84% (48 patients) improved to HE grade ≤ 2 following embolization ( p < 0.001). Higher MELD was not associated with worse outcome, and there was no difference in variceal bleeding or ascites post-embolization. Major procedural events occurred in seven patients (7%), with one LT and one death. Compared to matched historical controls without embolization ( n = 149), there was a reduction in LRD/LT in the embolization group (sHR 0.59, 95% CI 0.40–0.88, p = 0.010), persisting on inverse probability of treatment weighting. Conclusion SPSS embolization reduced severity and frequency of persistent HE in cirrhosis, and was not associated with increased ascites or variceal bleeding. The association of embolization with reduced LRD/LT requires further study.
No takes yet. Share an insight, caveat, or question.
Jeffrey et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: